FOI release

Freedom of Information responses from the MHRA - week commencing 27 June 2022

The Medicines and Healthcare products Regulatory Agency (MHRA) responses to freedom of information (FOI) requests for week commencing 27 June 2022

• From: Medicines and Healthcare products Regulatory Agency
• Published: 27 March 2023

Documents

Freedom of Information request on the ingredients used in the COVID-19 vaccines (FOI 22/757)

HTML

Freedom of Information request on the summary of risk management plan for Sucralfate (FOI 22/753)

HTML

Freedom of Information request on the product Alemtuzumab (FOI 22/771)

HTML

Freedom of Information request on the temporary authorisation of the COVID-19 vaccines (FOI 22/742)

HTML

Details

The Medicines and Healthcare products Regulatory Agency (MHRA) responses to freedom of information (FOI) requests for week commencing 27 June 2022